S2 Genomics
PrivateLast Round
Series A
Jan 23, 2024
Total Funding Raised
$16.28M
Company Overview
S2 Genomics is a life science tools company that provides automated tissue sample preparation systems for single-cell genomics and cell biology applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
S2 Genomics Comparables
Compare S2 Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellsonics | 87% | |
| Cell Microsystems | 82% | |
| LevitasBio | 82% |
S2 Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 23, 2024 | ||||
| Seed | Dec 11, 2019 | ||||
| Grant | Jun 26, 2018 |
S2 Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Seed |
| Research Corporation Technologies | Series A |
| NIH RADx | Grant |
| Life Science Angels | Seed |
| BroadOak Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors grew 119% MoM, reaching 1.4K.
- Mar 28, 2024
Grew 19% QoQ, from 26 to 31 employees.
S2 Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about S2 Genomics's valuation, stock price, and market status.
Is S2 Genomics a public or private company?
S2 Genomics is a private company.
What is the current stock price of S2 Genomics?
S2 Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is S2 Genomics worth (valuation)?
Valuation information for S2 Genomics is not publicly available.
Can I buy S2 Genomics stock?
S2 Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was S2 Genomics's last funding round?
S2 Genomics's most recent funding round was Series A on January 23, 2024.
Who are the main investors in S2 Genomics?
Key investors in S2 Genomics include Research Corporation Technologies, BroadOak Capital Partners.
Will S2 Genomics IPO soon?
No public IPO plans have been announced for S2 Genomics.
How can I track S2 Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor S2 Genomics's secondary market activity and sign up for updates.